Background: Coronary artery involvement is seen in approximately 15–20% of children with Kawasaki disease. There is conflicting literature regarding the clinical and laboratory findings associated with coronary artery involvement. In this retrospective study, we attempt identification of predictive factors for coronary artery involvement at our institute and review the existing literature. Methods and results: A review of 203 patients (65% males) with Kawasaki disease was performed, of whom 33 (16.3%) had coronary artery involvement. High erythrocyte sedimentation rate, high platelet count, low hematocrit, low albumin levels, and refractory Kawasaki disease showed significant association with coronary artery involvement. High erythrocyte sedimentation rate and refractory Kawasaki disease were found to be independent predictors of coronary artery involvement. Review of literature suggested a wide range of coronary involvement (<5% to >60%), and highly conflicting clinical and laboratory associations. Conclusion: It remains difficult to accurately determine risk of coronary artery involvement, although some laboratory markers may provide information that is helpful for parental counseling and clinical follow up. Future identification of novel biomarkers and host predispositions may further our understanding of coronary artery risks and help personalize therapy for Kawasaki disease.
References
[1]
Sabharwal, T.; Manlhiot, C.; Benseler, S.M.; Tyrrell, P.N.; Chahal, N.; Yeung, R.S.M.; McCrindle, B.W. Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. Am. J. Cardiol. 2009, 104, 1743–1747, doi:10.1016/j.amjcard.2009.07.062.
[2]
McCrindle, B.W.; Li, J.S.; Minich, L.L.; Colan, S.D.; Atz, A.M.; Takahashi, M.; Vetter, V.L.; Gersony, W.M.; Mitchell, P.D.; Newburger, J.W. Coronary artery involvement in children with Kawasaki disease risk factors from analysis of serial normalized measurements. Circulation 2007, 116, 174–179, doi:10.1161/CIRCULATIONAHA.107.690875.
[3]
Song, D.; Yeo, Y.; Ha, K.; Jang, G.; Lee, J.; Lee, K.; Son, C.; Lee, J. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur. J. Pediatr. 2009, 168, 1315–1321, doi:10.1007/s00431-009-0925-0.
[4]
Harada, K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr. Jpn. 1991, 33, 805–810, doi:10.1111/j.1442-200X.1991.tb02612.x.
[5]
Beiser, A.S.; Takahashi, M.; Baker, A.L.; Sundel, R.P.; Newburger, J.W. A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am. J. Cardiol. 1998, 81, 1116–1120, doi:10.1016/S0002-9149(98)00116-7.
[6]
Asai, T. Evaluation method for the degree of seriousness in Kawasaki disease. Pediatr. Int. 1983, 25, 170–175, doi:10.1111/j.1442-200X.1983.tb01683.x.
[7]
Newburger, J.W.; Takahashi, M.; Gerber, M.A.; Gewitz, M.H.; Tani, L.Y.; Burns, J.C.; Shulman, S.T.; Bolger, A.F.; Ferrieri, P.; Baltimore, R.S.; et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 2004, 110, 2747–2771, doi:10.1161/01.CIR.0000145143.19711.78.
[8]
Zhang, X.; Zhang, Z.; Liu, S.; Sun, J. Epidemiologic survey of Kawasaki disease in Jilin from 1999 through 2008. Pediatr. Cardiol. 2012, 33, 272–279, doi:10.1007/s00246-011-0121-7.
[9]
De Zorzi, A.; Colan, S.D.; Gauvreau, K.; Baker, A.L.; Sundel, R.P.; Newburger, J.W. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J. Pediatr. 1998, 133, 254–258, doi:10.1016/S0022-3476(98)70229-X.
[10]
Research Committee on Kawasaki Disease. Report of the Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease; Ministry of Health and Welfare: Tokyo, Japan, 1984.
[11]
Dallaire, F.; Dahdah, N. New equations and a critical appraisal of coronary artery Z scores in healthy children. J. Am. Soc. Echocardiogr. 2011, 24, 60–74, doi:10.1016/j.echo.2010.10.004.
[12]
Olivieri, L.; Arling, B.; Friberg, M.; Sable, C. Coronary artery Z score regression equations and calculators derived from a large heterogeneous population of children undergoing echocardiography. J. Am. Soc. Echocardiogr. 2009, 22, 159–164, doi:10.1016/j.echo.2008.11.003.
[13]
Belay, E.D.; Maddox, R.A.; Holman, R.C.; Curns, A.T.; Ballah, K.; Schonberger, L.B. Kawasaki syndrome and risk factors for coronary artery abnormalities. Pediatr. Infect. Dis. J. 2006, 25, 245–249, doi:10.1097/01.inf.0000202068.30956.16.
[14]
Ghelani, S.J.; Sable, C.; Wiedermann, B.L.; Spurney, C.F. Increased incidence of incomplete kawasaki disease at a pediatric hospital after publication of the 2004 American heart association guidelines. Pediatr. Cardiol. 2012, 33, 1097–1103, doi:10.1007/s00246-012-0232-9.
[15]
Fujiwara, T.; Fujiwara, H.; Nakano, H. Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Quantitative analysis. Circulation 1988, 78, 345–350, doi:10.1161/01.CIR.78.2.345.
[16]
Naoe, S.; Takahashi, K.; Masuda, H.; Tanaka, N. Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol. Jpn. 1991, 41, 785–797.
[17]
Takahashi, K.; Oharaseki, T.; Yokouchi, Y.; Yamada, H.; Shibuya, K.; Naoe, S. A half-century of autopsy results—Incidence of pediatric vasculitis syndromes, especially Kawasaki disease (in Chinese). Circ. J. 2012, 76, 964–970, doi:10.1253/circj.CJ-11-0928.
[18]
Gao, J.; Wang, H.-Y.; Wu, N.-J.; Zhang, S.-H. Relationship between fibrinogen Bβ-148C/T polymorphism and coronary artery lesions in children with Kawasaki disease. Zhongguo Dang Dai Er Ke Za Zhi 2010, 12, 518–520.
[19]
Sleeper, L.A.; Minich, L.L.; McCrindle, B.M.; Li, J.S.; Mason, W.; Colan, S.D.; Atz, A.M.; Printz, B.F.; Baker, A.; Vetter, V.L.; et al. Evaluation of kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J. Pediatr. 2011, 158, 831–835, doi:10.1016/j.jpeds.2010.10.031.
[20]
Ishihara, H.; Izumida, N.; Hosaki, J. Criterion for early prediction of coronary artery involvement by clinical manifestations in patients with Kawasaki disease. Bull. Tokyo Med. Dent. Univ. 1985, 32, 77–89.
[21]
Koren, G.; Lavi, S.; Rose, V.; Rowe, R. Kawasaki disease: Review of risk factors for coronary aneurysms. J. Pediatr. 1986, 108, 388–392, doi:10.1016/S0022-3476(86)80878-2.
[22]
Nakano, H.; Ueda, K.; Saito, A.; Tsuchitani, Y.; Kawamori, J.; Miyake, T.; Yoshida, T. Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms. Am. J. Cardiol. 1986, 58, 739–742, doi:10.1016/0002-9149(86)90348-6.
[23]
Nakano, M. Predictive factors of coronary aneurysm in Kawasaki disease—Correlation between coronary arterial lesions and serum albumin, cholinesterase activity, prealbumin, retinol-binding protein and immature neutrophils. Prog. Clin. Biol. Res. 1987, 250, 535–537.
[24]
Iwasa, M.; Sugiyama, K.; Ando, T.; Nomura, H.; Katoh, T.; Wada, Y. Selection of high-risk children for immunoglobulin therapy in Kawasaki disease. Prog. Clin. Biol. Res. 1987, 250, 543–544.
[25]
Ichida, F.; Fatica, N.S.; Engle, M.A.; O’Loughlin, J.E.; Klein, A.A.; Snyder, M.S.; Ehlers, K.H.; Levin, A.R. Coronary artery involvement in Kawasaki Syndrome in Manhattan, New York: Risk factors and role of aspirin. Pediatrics 1987, 80, 828–835.
[26]
Daniels, S.R.; Specker, B.; Capannari, T.E.; Schwartz, D.C.; Burke, M.J.; Kaplan, S. Correlates of coronary artery aneurysm formation in patients with Kawasaki disease. Am. J. Dis. Child. 1987, 141, 205–207.
[27]
Lu, C.P.; Lee, W.J.; Ho, M.M.; Hwang, K.C. Risk factors of coronary arterial aneurysm in Kawasaki disease. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1993, 34, 173–180.
[28]
Mori, M.; Imagawa, T.; Yasui, K.; Kanaya, A.; Yokota, S. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J. Pediatr. 2000, 137, 177–180, doi:10.1067/mpd.2000.107890.
[29]
Morikawa, Y.; Ohashi, Y.; Harada, K.; Asai, T.; Okawa, S.; Nagashima, M.; Katoh, T.; Baba, K.; Furusho, K.; Okuni, M.; et al. Coronary risks after high-dose gamma-globulin in children with Kawasaki disease. Pediatr. Int. 2000, 42, 464–469, doi:10.1046/j.1442-200x.2000.01288.x.
[30]
Nomura, Y.; Masuda, K.; Yoshinaga, M.; Sameshima, K.; Miyata, K. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm. Pediatr. Int. 2002, 44, 353–357, doi:10.1046/j.1442-200X.2002.01580.x.
[31]
Nofech-Mozes, Y.; Garty, B.-Z. Thrombocytopenia in Kawasaki disease: A risk factor for the development of coronary artery aneurysms. Pediatr. Hematol. Oncol. 2003, 20, 597–601.
[32]
Honkanen, V.E.A.; McCrindle, B.W.; Laxer, R.M.; Feldman, B.M.; Schneider, R.; Silverman, E.D. Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr. Cardiol. 2003, 24, 122–126, doi:10.1007/s00246-002-0063-1.
[33]
Chaiyarak, K.; Durongpisitkul, K.; Atta, T.; Soongswang, J.; Laohaprasitiporn, D.; Nana, A. Clinical manifestations of kawasaki disease: What are the significant parameters? Asian Pac. J. Allergy Immunol. 2009, 27, 131–136.
[34]
Durongpisitkul, K.; Soongswang, J.; Laohaprasitiporn, D.; Nana, A.; Prachuabmoh, C.; Kangkagate, C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr. Cardiol. 2003, 24, 145–148.
[35]
Kim, T.; Choi, W.; Woo, C.-W.; Choi, B.; Lee, J.; Lee, K.; Son, C.; Lee, J. Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur. J. Pediatr. 2007, 166, 421–425, doi:10.1007/s00431-006-0251-8.
[36]
Kim, J.-J.; Hong, Y.M.; Yun, S.W.; Han, M.K.; Lee, K.-Y.; Song, M.S.; Lee, H.-D.; Kim, D.S.; Sohn, S.; Ha, K.-S.; et al. Assessment of risk factors for Korean children with Kawasaki disease. Pediatr. Cardiol. 2011, 33, 513–520.
[37]
Kaneko, K.; Yoshimura, K.; Ohashi, A.; Kimata, T.; Shimo, T.; Tsuji, S. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide. Pediatr. Cardiol. 2011, 32, 1106–1109, doi:10.1007/s00246-011-9986-8.
[38]
Chen, J.; Liu, Y.; Liu, W.; Wu, Z. A meta-analysis of the biomarkers associated with coronary artery lesions secondary to Kawasaki disease in Chinese children. J. Huazhong Univ. Sci. Technol. (Med. Sci.) 2011, 31, 705–711, doi:10.1007/s11596-011-0587-9.
[39]
Tremoulet, A.H.; Jain, S.; Chandrasekar, D.; Sun, X.; Sato, Y.; Burns, J.C. Evolution of laboratory values in patients with Kawasaki disease. Pediatr. Infect. Dis. J. 2011, 30, 1022–1026, doi:10.1097/INF.0b013e31822d4f56.
[40]
Caballero-Mora, F.J.; Alonso-Martín, B.; Tamariz-Martel-Moreno, A.; Cano-Fernández, J.; Sánchez-Bayle, M. Kawasaki disease in 76 patients. Risk factors for coronary artery aneurysms. An. Pediatr. (Barc.) 2011, 74, 232–238, doi:10.1016/j.anpedi.2010.11.024.
[41]
Weng, K.-P.; Hsieh, K.-S.; Huang, S.-H.; Ou, S.-F.; Ma, C.-Y.; Ho, T.-Y.; Lai, C.-R.; Ger, L.-P. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease. Kaohsiung J. Med. Sci. 2012, 28, 23–29, doi:10.1016/j.kjms.2011.09.002.
[42]
Burns, J.C.; Glode, M.P.; Clarke, S.H.; Wiggins, J., Jr.; Hathaway, W.E. Coagulopathy and platelet activation in Kawasaki syndrome: Identification of patients at high risk for development of coronary artery aneurysms. J. Pediatr. 1984, 105, 206–211, doi:10.1016/S0022-3476(84)80114-6.
[43]
Yu, H.-R.; Kuo, H.-C.; Huang, E.-Y.; Liang, C.-D.; Hwang, K.-P.; Lin, I.-C.; Sheen, J.-M.; Wang, T.-J.; Wang, C.-L.; Yang, K.D. Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease. Pediatr. Cardiol. 2010, 31, 1151–1156, doi:10.1007/s00246-010-9769-7.
[44]
Kuo, H.-C.; Yang, Y.-L.; Chuang, J.-H.; Tiao, M.-M.; Yu, H.-R.; Huang, L.-T.; Yang, K.D.; Chang, W.-C.; Lee, C.-P.; Huang, Y.-H. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease. J. Clin. Immunol. 2012, 32, 746–752, doi:10.1007/s10875-012-9668-1.
[45]
Hsieh, K.-S.; Lai, T.-J.; Hwang, Y.-T.; Lin, M.-W.; Weng, K.-P.; Chiu, Y.-T.; Ho, T.-Y.; Chen, C.-S.; Shiue, Y.-L.; Hsiao, M.; et al. IL-10 promoter genetic polymorphisms and risk of Kawasaki disease in Taiwan. Dis. Markers 2011, 30, 51–59.
[46]
Hsieh, Y.-Y.; Lin, Y.-J.; Chang, C.-C.; Chen, D.-Y.; Hsu, C.-M.; Wang, Y.-K.; Hsu, K.-H.; Tsai, F.-J. Human lymphocyte antigen B-associated transcript 2, 3, and 5 polymorphisms and haplotypes are associated with susceptibility of Kawasaki disease and coronary artery aneurysm. J. Clin. Lab. Anal. 2010, 24, 262–268, doi:10.1002/jcla.20409.
[47]
Huang, Y.-C.; Lin, Y.-J.; Chang, J.-S.; Chen, S.-Y.; Wan, L.; Sheu, J.J.-C.; Lai, C.-H.; Lin, C.-W.; Liu, S.-P.; Chen, C.-P.; et al. Single nucleotide polymorphism rs2229634 in the ITPR3 gene is associated with the risk of developing coronary artery aneurysm in children with Kawasaki disease. Int. J. Immunogenet. 2010, 37, 439–443, doi:10.1111/j.1744-313X.2010.00943.x.
[48]
Kuo, H.-C.; Yang, K.D.; Juo, S.-H.H.; Liang, C.-D.; Chen, W.-C.; Wang, Y.-S.; Lee, C.-H.; Hsi, E.; Yu, H.-R.; Woon, P.-Y.; et al. ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One 2011, 6, doi:10.1371/journal.pone.0017370.
[49]
Mamtani, M.; Matsubara, T.; Shimizu, C.; Furukawa, S.; Akagi, T.; Onouchi, Y.; Hata, A.; Fujino, A.; He, W.; Ahuja, S.K.; et al. Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki disease, coronary artery lesions, and IVIG responses in Japanese children. PLoS One 2010, 5, doi:10.1371/journal.pone.0011458.
[50]
Onouchi, Y. Identification of susceptibility genes for Kawasaki disease. Jpn. J. Clin. Immunol. 2010, 33, 73–80, doi:10.2177/jsci.33.73.
[51]
Onouchi, Y.; Suzuki, Y.; Suzuki, H.; Terai, M.; Yasukawa, K.; Hamada, H.; Suenaga, T.; Honda, T.; Honda, A.; Kobayashi, H.; et al. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease. Pharmacogenomics J. 2013, 13, 52–59, doi:10.1038/tpj.2011.45.
[52]
Hata, A.; Onouchi, Y. Susceptibility genes for Kawasaki disease: Toward implementation of personalized medicine. J. Hum. Genet. 2009, 54, 67–73, doi:10.1038/jhg.2008.9.
[53]
Khor, C.C.; Davila, S.; Shimizu, C.; Sheng, S.; Matsubara, T.; Suzuki, Y.; Newburger, J.W.; Baker, A.; Burgner, D.; Breunis, W.; et al. Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J. Med. Genet. 2011, 48, 467–472, doi:10.1136/jmg.2010.086611.
[54]
Khor, C.C.; Davila, S.; Breunis, W.B.; Lee, Y.-C.; Shimizu, C.; Wright, V.J.; Yeung, R.S.M.; Tan, D.E.K.; Sim, K.S.; Wang, J.J.; et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat. Genet. 2011, 43, 1241–1246, doi:10.1038/ng.981.
[55]
Kim, S.K.; Kang, S.W.; Chung, J.-H.; Lee, J.S.; Park, H.K.; Yoon, K.L.; Kim, S.C. Coding single-nucleotide polymorphisms of interleukin-1 gene cluster are not associated with Kawasaki disease in the Korean population. Pediatr. Cardiol. 2011, 32, 381–385, doi:10.1007/s00246-010-9858-7.
[56]
Masi, L.; Franceschelli, F.; Leoncini, G.; Gozzini, A.; Rigante, D.; La Torre, F.; Matucci-Cerinic, M.; Brandi, M.L.; Falcini, F. Can fibroblast growth factor (FGF)-23 circulating levels suggest coronary artery abnormalities in children with Kawasaki disease? Clin. Exp. Rheumatol. 2013, 31, 149–153.
Yamamura, K.; Ihara, K.; Ikeda, K.; Nagata, H.; Mizuno, Y.; Hara, T. Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease. Int. J. Immunogenet. 2012, 39, 119–125, doi:10.1111/j.1744-313X.2011.01065.x.
